These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19468981)

  • 1. Myeloproliferative disorder therapy: assessment and management of adverse events--a psychiatrist's perspective.
    McDonald G
    Hematol Oncol; 2009 Jun; 27 Suppl 1():14-6. PubMed ID: 19468981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloproliferative disorder therapy: assessment and management of adverse events--a cardiologist's perspective.
    Kenny D
    Hematol Oncol; 2009 Jun; 27 Suppl 1():8-10. PubMed ID: 19468985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloproliferative disorder therapy: assessment and management of adverse events--a dermatologist's perspective.
    Soutou B; Aractingi S
    Hematol Oncol; 2009 Jun; 27 Suppl 1():11-3. PubMed ID: 19468982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives in managing myeloproliferative disorders: focus on the patient.
    Birgegård G
    Hematol Oncol; 2009 Jun; 27 Suppl 1():5-7. PubMed ID: 19468983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders.
    Spivak JL; Hasselbalch H
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):403-14. PubMed ID: 21417854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining targets in myeloproliferative disorders: reflecting on what is important.
    Griesshammer M
    Hematol Oncol; 2009 Jun; 27 Suppl 1():2-4. PubMed ID: 19468984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sport psychiatrist and golf.
    Clark TP; Tofler IR; Lardon MT
    Clin Sports Med; 2005 Oct; 24(4):959-71, xi. PubMed ID: 16169456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current world literature.
    Curr Opin Hematol; 2010 Mar; 17(2):139-53. PubMed ID: 20145442
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of chronic myeloproliferative disorders].
    Ikkala E; Hormila P
    Duodecim; 1989; 105(11):1007-15. PubMed ID: 2473873
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon-alpha for treatment of essential thrombocythemia during pregnancy: case report and review of the literature.
    Séror J; Sentilhes L; Lefebvre-Lacoeuille C; Marpeau L
    Fetal Diagn Ther; 2009; 25(1):136-40. PubMed ID: 19279390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer patients' reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: a preliminary study.
    Okuyama T; Endo C; Seto T; Kato M; Seki N; Akechi T; Furukawa TA; Eguchi K; Hosaka T
    Palliat Support Care; 2009 Jun; 7(2):229-33. PubMed ID: 19538806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment and management of delirium in cancer patients.
    Bush SH; Bruera E
    Oncologist; 2009 Oct; 14(10):1039-49. PubMed ID: 19808772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression often undertreated in HIV/AIDS patients, psychiatrist warns.
    Silversides A
    CMAJ; 1998 Feb; 158(3):391-2. PubMed ID: 9484269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary complications of cytostatic treatment of hemoblastosis].
    Plank L; Buchanec J
    Cesk Pediatr; 1980 Mar; 35(3):164-6. PubMed ID: 7397892
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of severe deafness in adults. The psychiatrist's contribution.
    Denmark JC
    Proc R Soc Med; 1969 Sep; 62(9):965-7. PubMed ID: 5823823
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection and management of depression in patients with vision impairment.
    Fenwick EK; Lamoureux EL; Keeffe JE; Mellor D; Rees G
    Optom Vis Sci; 2009 Aug; 86(8):948-54. PubMed ID: 19609229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient myeloproliferative disorder and eosinophilic pericardial effusion in a down syndrome neonate.
    Shenoy RD; Bhat KG; Kamath N; Kumble Y
    Pediatr Hematol Oncol; 2008 Mar; 25(2):123-9. PubMed ID: 18363179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous side effects of a long-term treatment by hydroxyurea].
    Steels E; Heenen M; Germaux MA; Moens JP
    Rev Med Brux; 2006; 27(1):39-41. PubMed ID: 16608010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The debate concerning the classification of depression that predominantly occurred in the United Kingdom from 1926 to 1957: the discovery and reappraisal of "mild endogenous depression"].
    Ohmae S
    Seishin Shinkeigaku Zasshi; 2009; 111(5):486-501. PubMed ID: 19624094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2 inhibitors: not the next imatinib but researchers see other possibilities.
    Garber K
    J Natl Cancer Inst; 2009 Jul; 101(14):980-2. PubMed ID: 19584324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.